Clinical study for the effect of Zhishi Tongjiang Granule on postoperative ileus

To discuss the mechanism of Zhishi Tongjiang Granules in the prevention and treatment of postoperative inflammatory ileus based on the inflammatory initiator cell - the interstitial cell of Cajal - smooth muscle axis

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023379

Enrollment

Unknown

Registered

2019-05-25

Start date

2019-06-01

Completion date

Unknown

Last updated

2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative ileus

Interventions

Chinese medicine group:taking zhishi tongjiang granule

control group:oral placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Meet the diagnostic criteria for colorectal cancer; The tumor stage is in the second stage and below, and there are indications for radical surgery, which is in line with the principle of surgical treatment; Aged 18 to 70 years.

Exclusion criteria

Exclusion criteria: Pregnancy and preparation for pregnancy or lactation women; Patients with cardiovascular and cerebrovascular, liver, kidney, endocrine and hematopoietic, severe primary diseases of the nervous system, and persons with legal disabilities; Patients who are unwilling to join a clinical trial.

Design outcomes

Primary

Measure	Time frame
Serum inflammatory cytokines and markers of infection;Postoperative time of first anal exhaust and defecation;	—

Countries

China

Contacts

Public ContactMo Li

The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine

497489069@qq.com+86 13874932396

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026